Cutler Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Cutler Group’s Portfolio PHAS Stock Details PHAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	–	–	5638
2022 Q3	$0	Hold	1,000	–	–	﹤0.01%	5807
2022 Q2	$0	Hold	1,000	–	–	﹤0.01%	6001
2022 Q1	$1K	Hold	1,000	–	–	﹤0.01%	5186
2021 Q4	$2K	Hold	1,000	–	–	﹤0.01%	4894
2021 Q3	$3K	Hold	1,000	–	–	﹤0.01%	4933
2021 Q2	$3K	Hold	1,000	–	–	﹤0.01%	4899
2021 Q1	$3K	Hold	1,000	–	–	﹤0.01%	4819
2020 Q4	$3K	Buy	1,000 +600	+150%	+$2.15K	﹤0.01%	4063
2020 Q3	$1K	Sell	400 -300	-43%	-$1.21K	﹤0.01%	4540
2020 Q2	$3K	Buy	+700	New	+$3.1K	﹤0.01%	3695

Other funds holding PHAS

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HLA

Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

IIA

IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Cutler Group's PHAS Position: Q4 2022 in Review

Cutler Group sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q4 2022, closing a stake of 1,000 shares.

Cutler Group first reported a position in PHAS in Q2 2020 and held it in 10 quarters. The position peaked at $3K in Q3 2021. 5 funds tracked by Wall St. Rank hold PHAS as of Q4 2022.

Cutler Group reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cutler Group sold 1,000 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q4 2022.
Cutler Group first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Cutler Group's PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q3 2021.
5 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.